Theme 1

Pathogenesis of CLL

Session 1: Molecular Pathogenesis of CLL: Genomics and Proteomics
Session 2: Molecular Pathogenensis of CLL: Microenvironment and Signaling
Session 3: Clonal Dynamics, Competition, and Disease Evolution

Theme 2

Approach Considerations and Treatment Options in CLL

Session 4: Prognostication and Prediction in the Era of Novel Drugs
Industry Supported Symposium
Session 5: Minimal Residual Disease: Methods and Clinical Application
Industry Supported Symposium
Session 6: Frontline Therapy for CLL
Session 7: Treatment of Relapsed/Refractory CLL
Industry Supported Symposium

Theme 3

Rationally Designed Therapy on the Horizon in CLL

Session 8: New Agents in CLL Clinical Trials
Session 9: Immunotherapy for CLL
Session 10: Supportive Care and Consequences of Immune Dysregulation in CLL
Session 11: iwCLL Updates